This seminar provides an update on the legal framework, regulatory expectations and practical implementation of GDP in Switzerland.
Gain a comprehensive understanding of the legal and regulatory framework for the distribution of medicinal products in Switzerland.
Learn how to implement and maintain a GDP-compliant quality system, including documentation, qualification, and validation of critical distribution steps.
Discuss the roles, tasks, and liability of the Responsible Person (Fachtechnisch Verantwortliche Person, FvP).
Exchange experience and best practices with experts from industry, authority, and legal practice.
Apply regulatory expectations to real-life examples, including transport validation, vehicle qualification, and stability considerations during storage and shipment.
Hintergrund
Quality requirements for medicines do not end after production and packaging. Medicines and APIs are often shipped over long distances and across different climate zones and stored in various warehouses.
Companies are required to demonstrate that all activities related to storage, handling, and transport are conducted under controlled and monitored conditions. The increasing complexity of global supply chains, temperature-sensitive products, and multiple distribution partners make it essential to have a well-established quality system in place. It is expected to ensure that processes are transparent, traceable, and continuously improved.
This course provides a comprehensive overview of key aspects of pharmaceutical distribution in Switzerland and offers practical insights into how GDP requirements can be translated into daily operations.
Zielgruppe
This course has been designed for employees, specialists and managers from storage, transportation and distribution as well as their colleagues from quality control, quality assurance and production, which are involved in the various processes of drug logistics.
Date / Venue / Presentations / Certificate
Date Tuesday, 08 September 2026, 9.00 - 17.30 h (Registration and coffee 8.30 - 9.00 h)
The presentations for this event will be available for you to download and print before and after the event. Please note that no printed materials will be handed out on site and that there will not be any opportunity to print the presentations on site.
After the event, you will automatically receive your certificate of participation.
Legal Bases for the Distribution of Medicinal Products
Swiss Law and European Law - Act on Therapeutic Products - Ordinance on Establishment Licences - European Guidelines on Good Distribution Practice of Medicinal Products for Human Use (GDP) - European GDP Guidelines for Active Substances
Outsourced activities
Written contract for outsourced activities
Tasks and Responsibilities
General considerations on GDP in Switzerland
Legal Basis
Revision of the Therapeutic Products Act (HMG) and ist effects
Authorization types
GDP Requirements
Quality in the supply chain
Technically Responsible Person (FvP) - General
FvP - Delegation
Liability
Responsibility and liability: Terms
Different kinds of responsibilities - Administrative responsibility - Civil responsibility - Criminal responsibility
Protection of the Responsible Person
The Responsible Person in case law
Practical Implementation in Switzerland
The GDP inspection: preparation and implementation
Wholesale vs. pre-wholesale: demarcation and similarities
Transport in accordance with storage conditions: best practices
Case study: validation of transport routes, qualification of transport vehicles
Storage and Transport: Practical Aspects (Interactive Session)
b) Transport - Transport qualification/ validation - Transport at ambient conditions: expectations and control - Deviation management - Cool and cold chain - Risk Analysis - Training
Teilnehmerstimmen - das sagen andere über unsere Seminare:
„Flüssiger Vortrag, neue Aspekte wurden kommuniziert.“ Rainer Tryankowski, DRK-Blutspendedienst Rheinland-Pfalz und Saarland Webinar GDP Update 2025 März 2025
„Sehr guter Überblick über die aktuellen GDP Themen. Sehr kurzweilig.“ Juliana Dodillet, Pharma Resources GmbH Webinar GDP Update 2025 März 2025
„Sehr ausführliche Erklärung“ Jacqueline Buckel, UNITAX-Pharmalogistik GmbH Webinar GDP Update 2025 März 2025
„Sehr gut: praxisorientiert; Präsentation logisch nachvollziehbar“ Gabriele Unger, Astro-Pharma GmbH Webinar GDP Update 2025 März 2025
„Sehr informativ und umfangreich, aber immer auf den Punkt gebracht“ Jasmine Merz, Peppler GmbH Webinar GDP Update 2025 März 2025